Welcome to our dedicated page for WEX SEC filings (Ticker: WEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
WEX Inc. filings document formal disclosures for a NYSE-listed payment technology company with common stock registered under the symbol WEX. Recent Form 8-K reports cover results of operations and financial condition through earnings releases and investor supplements, including revenue, margin, guidance and payment-volume disclosures tied to the company's Mobility, Benefits and Corporate Payments activities.
The filing record also includes material agreements, Regulation FD disclosures, board and director changes, annual meeting and proxy-related matters, and governance disclosures such as board size, director independence and leadership roles. These documents record WEX's public-company capital structure, reporting obligations, and corporate governance developments.
WEX Inc. executive Carlos Carriedo, COO, Amer. Payments & Mobility, reported selling 1,075 shares of common stock on August 4, 2026 at $186.00 per share in an open-market or private transaction. Following this sale, he directly holds 11,076 shares of WEX common stock.
FMR LLC filed a Schedule 13G reporting beneficial ownership of common stock of WEX INC. FMR LLC reports beneficially owning 1,801,385.10 shares of WEX common stock, representing 5.2% of the class, with sole dispositive power over the full position and no shared dispositive or voting power.
Abigail P. Johnson is also reported as a beneficial owner of the same 1,801,385.10 shares, with sole dispositive power and no voting or shared powers. One or more other persons have rights to receive dividends or sale proceeds from these shares, but no such person has more than five percent of the total outstanding WEX common stock.
A shareholder of WEX filed a notice of proposed sale of common stock under Rule 144. The shares were originally acquired as compensation through Restricted Stock Units (RSUs) granted on May 14, 2021 (1,261 shares) and June 4, 2022 (760 shares). Goldman Sachs & Co. LLC is listed as the broker for the planned transactions, with sales expected to be made on the NYSE around July 31, 2026. The filing documents the intent to sell these compensation-related shares in compliance with Rule 144 resale requirements.
WEX Inc. reports that COO, Benefits Robert Joseph Deshaies sold 1,000 shares of Common Stock on July 30, 2026 in a sale described as an open market or private transaction at a weighted average price of about $184.95 per share, with individual sale prices between $184.92 and $185.00. Following this transaction, he directly owns 19,288 shares of WEX Inc. common stock.
WEX Inc. insider Robert Deshaies has filed to sell common stock through Merrill Lynch on the NYSE. The notice covers a planned sale of 1,000 shares of WEX common stock on or about July 30, 2026.
The filing also reports prior sales of WEX common stock during the past three months, including 2,000 shares sold on July 6, 2026 for an aggregate amount of 296,737, and 1,200 shares sold on May 28, 2026 for an aggregate amount of 173,764.
WEX Inc. executive Drew Ann Elena, Chief Risk and Compliance, reported selling 3,400 shares of common stock on July 27, 2026. The sale was reported at a weighted average price of $176.02 per share, with individual trades between $176.00 and $176.29. After this transaction, she directly holds 7,988 shares of WEX common stock. The transaction was reported as a sale in the open market or a private transaction and was not designated as pursuant to a Rule 10b5‑1 trading plan.
WEX Inc. Chief Accounting Officer Jennifer Kimball reported selling 1,183 shares of common stock on 2026-07-27 in a sale classified as an open market or private transaction at $176.55 per share. After this sale, she directly owns 4,916 shares. The transaction was not marked as made pursuant to a Rule 10b5-1 trading plan.
WEX Inc. filed a notice of proposed sale of common stock, indicating sales through Merrill Lynch in Washington, DC, with trading on the NYSE and a reference date of 07/27/2026. The filing also lists multiple prior transactions labeled as “Stock plan activity” with the issuer across 2022, 2023, and 2026, each showing associated numerical amounts.